Clinical Study
Long term efficacy and patient satisfaction of microvascular decompression and gamma knife radiosurgery for trigeminal neuralgia

https://doi.org/10.1016/j.jocn.2014.11.028Get rights and content

Abstract

The aim of our study was to evaluate the long term efficacy of microvascular decompression (MVD) and gamma knife radiosurgery (GKRS) with respect to pain relief and patient satisfaction. Both these modalities are accepted modalities of treatment for intractable trigeminal neuralgia. We excluded deceased patients, those who had a prior intervention and those requiring an additional intervention following initial treatment. A total of 69 patients were included in the study. Of these, 49 patients underwent treatment by GKRS and 20 by MVD. Pain status was assessed using the Barrow Neurological Institute (BNI) pain scale. The median follow up was 5.3 years. There was no significant difference between the two groups with respect to initial pain relief (100% MVD, 84% GKRS; p = 0.055). There was no significant difference in pain recurrence between the two groups (39% GKRS, 20% MVD; p = 0.133). At last follow up, 85% of patients who underwent MVD had total pain relief (BNI scale I) compared to only 45% of GKRS patients (p = 0.002). There was no significant difference in the patient satisfaction with respect to undergoing the same procedure again (90% MVD, 69% GKRS; p = 0.1) and recommending it to family members (95% MVD, 84% GKRS; p = 0.2). MVD offered total pain relief in a significantly higher number of patients than GKRS. There was no significant difference in the patient satisfaction rate between the two groups.

Introduction

In one of the epidemiological studies conducted in the USA, the incidence rate of trigeminal neuralgia was 4.3 per 100,000 population and the age adjusted rate for women was significantly higher than that for men [1]. Medical management is the main stay of therapy for idiopathic trigeminal neuralgia and surgery is indicated when medical therapy fails. Various surgical treatment modalities include microvascular decompression (MVD), balloon compression, radiofrequency thermocoagulation, glycerol rhizolysis, partial sensory rhizotomy (posterior fossa), cryotherapy and neurectomy or alcohol injections. Of all these surgical modalities, MVD is more popular and it is the only non ablative technique. Gamma knife radiosurgery (GKRS) is gaining popularity for treating idiopathic trigeminal neuralgia not only due to its non-invasive nature but also because patients can be discharged on the same day with acceptable results.

We performed this study due to the lack of available literature with respect to efficacy of both MVD and GKRS treatment modalities and patient satisfaction. To our knowledge, there are only two prospective studies [2], [3] which have compared MVD and GKRS. In one study the results did not reach statistical significance [2]. In another study, [3] MVD was superior to GKRS in achieving pain free status. We also identified only two patient satisfaction surveys with regards to MVD or GKRS [3], [4]. Out of these, only one compares MVD and GKRS in terms of patient satisfaction [3]. Our study is the second such satisfaction survey.

MVD and GKRS are both accepted modalities of treatment for intractable trigeminal neuralgia. The aim of our study was to evaluate the long term efficacy of both these modalities with respect to pain relief and patient satisfaction. We attempted to evaluate the pain relief patterns after treatment for trigeminal neuralgia following GKRS and MVD.

Section snippets

Methods

The study was approved by our Institutional Review Board. Patients were briefed about the survey and after getting verbal consent from the patient, a telephone interview with a standardized questionnaire was conducted. Telephone interviews were conducted to assess the pain status and complete the patient satisfaction survey. Pain status was assessed using the Barrow Neurological Institute (BNI) pain scale. Patient satisfaction with respect to whether they would undergo the same procedure again

Results

A total of 69 patients with successful telephone interviews were included in the final analysis. Of these, 49 (71%) underwent GKS and 20 (29%) underwent MVD. There was no significant difference in the age between the two groups (MVD 61.3 years versus GKRS 63.39 years; independent sample t-test). The majority of the patients were women (66.7%). There was no difference in the gender distribution among the two groups. The median follow up period was 5.3 years.

Discussion

Current options for patients who have inadequate or only a transient relief with medications include MVD or several palliative destructive procedures like rhizotomy directed at the trigeminal nerve root or ganglion. Though MVD is currently the most frequently reported procedure, not a single randomized controlled trial was identified [5]. MVD like any other surgical procedure is associated with complications like mortality, infection or those related to general anesthesia, and the mortality

Conclusions

From our study, MVD offered total pain relief in significantly higher number of patients than GKRS. There was no significant difference in the rates of patient satisfaction between the two groups although there was a trend for greater satisfaction after MVD. Our observations regarding long term efficacy of MVD are similar to those published in the literature, but there is a lack of high quality evidence to support the clinical practice. Properly matched prospective studies or randomized

Conflicts of Interest/Disclosures

The authors declare that they have no financial or other conflicts of interest in relation to this research and its publication.

References (27)

  • R.F. Sekula et al.

    Microvascular decompression for elderly patients with trigeminal neuralgia: a prospective study and systematic review with meta-analysis

    J Neurosurg

    (2011)
  • F.G. Barker et al.

    The long-term outcome of microvascular decompression for trigeminal neuralgia

    N Engl J Med

    (1996)
  • G. Broggi et al.

    Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis

    J Neurol Neurosurg Psychiatry

    (2000)
  • Cited by (35)

    • Microvascular Decompression Versus Gamma Knife Surgery in Patients with Drug-Resistant Trigeminal Neuralgia: A Systematic Review and Meta-Analysis

      2022, World Neurosurgery
      Citation Excerpt :

      Another option is Gamma knife surgery (GKS), a non-invasive technique that delivers high-dose radiation to the fifth cranial nerve. This outpatient procedure does not need general anesthesia.6 The standard gold surgery is MVD nowadays, but it is still a challenge to choose between MVD and GKS.

    • Teflon Granuloma: A Common Cause of Recurrent Trigeminal Neuralgia

      2022, World Neurosurgery
      Citation Excerpt :

      In general, pain recurring within a month is deemed invalid. It has been reported that recurrence rate of TN was 3%–31%,5,9-13 improvement of diagnostic techniques and different medical levels may be responsible for such a huge cliff. Concerns about complications of re-do MVD14 and psychological rejections, many patients with recurrent TN opted for medications or some "minimally invasive operations".15-19

    • Microvascular Decompression versus Stereotactic Radiosurgery for Trigeminal Neuralgia: A Single-Institution Experience

      2020, World Neurosurgery
      Citation Excerpt :

      MVD is historically the most frequently reported procedure for medically intractable TN. Through univariate ordinal regression analysis, we found that MVD provides a more favorable outcome compared with SRS, similar to other studies reported in the literature.6,11,12,37 MVD is more prevalent in females; moreover, younger patients (age <65 years) tends to undergo MVD, whereas older patients (age >65 years) are more likely to undergo SRS.4

    • Treatment Outcomes in Trigeminal Neuralgia–A Systematic Review of Domains, Dimensions and Measures

      2020, World Neurosurgery: X
      Citation Excerpt :

      The IMMPACT Outcome Domains are as follows: 1) Pain; 2) Physical functioning; 3) Emotional functioning; 4) Participant ratings of global improvement/satisfaction; 5) Symptoms and adverse events; and 6) Participant disposition. With the exception of 8 papers, all studies used pain as an outcome domain (Figure 2 and Table 1).13-459 Symptoms and adverse events also were described in a high number of papers (n = 386); however, the impact of treatment on physical and emotional functioning was significantly less evaluated, in 46 and 17 studies, respectively (Tables 2 and 3).460-464

    View all citing articles on Scopus
    View full text